Sirtuin 1 in skeletal muscle of cachectic tumour-bearing rats: A role in impaired regeneration?

Journal of Cachexia, Sarcopenia and Muscle

Volumn 2, Issue 1, 2011, Pages 57-62

  Toledo, Míriam ^a   Busquets, Sílvia ^a   Ametller, Elisabet ^a   López Soriano, Francisco J ^a   Argilés, Josep M ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Cachexia; Muscle wasting; PGC1 alpha; Sirt1

Indexed keywords

FORMOTEROL; MESSENGER RNA; MYOD PROTEIN; MYOGENIN; SIRTUIN 1; TRANSCRIPTION FACTOR PAX7;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CACHEXIA; CELL DIFFERENTIATION; CONTROLLED STUDY; EXTENSOR DIGITORUM LONGUS MUSCLE; GASTROCNEMIUS MUSCLE; GENE EXPRESSION; MALE; MUSCLE ATROPHY; MUSCLE MASS; MUSCLE REGENERATION; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; TIBIALIS ANTERIOR MUSCLE; TIBIALIS POSTERIOR MUSCLE; WEIGHT REDUCTION;

EID: 84862891163     PISSN: 21905991     EISSN: 21906009     Source Type: Journal    
DOI: 10.1007/s13539-011-0018-6     Document Type: Article

References (46)

1. Harvey KB, Bothe Jr A, Blackburn GL. Nutritional assessment and patient outcome during oncological therapy. Cancer. 1979; 43: 2065-9.
2. Argiles JM, Alvarez B, Lopez-Soriano FJ. The metabolic basis of cancer cachexia. Med Res Rev. 1997; 17: 477-98.
3. Argiles JM, Lopez-Soriano FJ. The ubiquitin-dependent proteolytic pathway in skeletal muscle: its role in pathological states. Trends Pharmacol Sci. 1996; 17: 223-6.
4. Sanchis D et al. Skeletal muscle UCP2 and UCP3 gene expression in a rat cancer cachexia model. FEBS Lett. 1998; 436: 415-8.
5. van Royen M et al. DNA fragmentation occurs in skeletal muscle during tumor growth: a link with cancer cachexia? Biochem Biophys Res Commun. 2000; 270: 533-7.
6. Michishita E et al. Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins. Mol Biol Cell. 2005; 16: 4623-35.
7. Haigis MC, Guarente LP. Mammalian sirtuins-emerging roles in physiology, aging, and calorie restriction. Genes Dev. 2006; 20: 2913-21.
8. Shi T et al. SIRT3, a mitochondrial sirtuin deacetylase, regulates mitochondrial function and thermogenesis in brown adipocytes. J Biol Chem. 2005; 280: 13560-7.
9. Ashraf N et al. Altered sirtuin expression is associated with node-positive breast cancer. Br J Cancer. 2006; 95: 1056-61.
10. Palacios OM et al. Diet and exercise signals regulate SIRT3 and activate AMPK and PGC-1alpha in skeletal muscle. Aging (Albany NY). 2009; 1: 771-83.
11. Chen D et al. Tissue-specific regulation of SIRT1 by calorie restriction. Genes Dev. 2008; 22: 1753-7.
12. Stock MJ, Rothwell NJ. Effects of β-adrenergic agonists on metabolism and body composition. In: Buttery PJ, Hayes NB, Lindsay DB, editors. Control and manipulation of animal growth. London: Butterworths; 1985. p. 249-57.
13. Kim YS, Sainz RD. beta-Adrenergic agonists and hypertrophy of skeletal muscles. Life Sci. 1992; 50: 397-407.
14. Agbenyega ET, Wareham AC. Effect of clenbuterol on skeletal muscle atrophy in mice induced by the glucocorticoid dexamethasone. Comp Biochem Physiol Comp Physiol. 1992; 102: 141-5.
15. Rajab P et al. Skeletal muscle myosin heavy chain isoforms and energy metabolism after clenbuterol treatment in the rat. Am J Physiol Regul Integr Comp Physiol. 2000; 279: R1076-81.
16. Hinkle RT et al. Skeletal muscle hypertrophy and anti-atrophy effects of clenbuterol are mediated by the beta2-adrenergic receptor. Muscle Nerve. 2002; 25: 729-34.
17. Wineski LE et al. Muscle-specific effects of hindlimb suspension and clenbuterol in mature male rats. Cells Tissues Organs. 2002; 171: 188-98.
18. Busquets S et al. Anticachectic effects of formoterol: a drug for potential treatment of muscle wasting. Cancer Res. 2004; 64: 6725-31.
19. Luz MA, Marques MJ, Santo Neto H. Impaired regeneration of dystrophin-deficient muscle fibers is caused by exhaustion of myogenic cells. Braz J Med Biol Res. 2002; 35: 691-5.
20. Seale P et al. Pax7 is required for the specification of myogenic satellite cells. Cell. 2000; 102: 777-86.
21. Schultz E, Gibson MC, Champion T. Satellite cells are mitotically quiescent in mature mouse muscle: an EM and radioautographic study. J Exp Zool. 1978; 206: 451-6.
22. Schultz E, McCormick KM. Skeletal muscle satellite cells. Rev Physiol Biochem Pharmacol. 1994; 123: 213-57.
23. Ryall JG et al. Intramuscular beta2-agonist administration enhances early regeneration and functional repair in rat skeletal muscle after myotoxic injury. J Appl Physiol. 2008; 105: 165-72.
24. Roberts P, McGeachie JK. The enhancement of revascularisation of skeletal muscle transplants using the beta 2-agonist isoprenaline. J Anat. 1994; 184: 309-18.
25. Grounds MD, Yablonka-Reuveni Z. Molecular and cell biology of skeletal muscle regeneration. Mol Cell Biol Hum Dis Ser. 1993; 3: 210-56.
26. Roberts P, McGeachie JK. The effects of clenbuterol on satellite cell activation and the regeneration of skeletal muscle: an autoradiographic and morphometric study of whole muscle transplants in mice. J Anat. 1992; 180: 57-65.
27. Lynch GS, Schertzer JD, Ryall JG. Anabolic agents for improving muscle regeneration and function after injury. Clin Exp Pharmacol Physiol. 2008; 35: 852-8.
28. Ryall JG, Church JE, Lynch GS. Novel role for beta-adrenergic signalling in skeletal muscle growth, development and regeneration. Clin Exp Pharmacol Physiol. 2010; 37: 397-401.
29. Ametller E et al. Formoterol may activate rat muscle regeneration during cancer cachexia. Insciences Journal. 2011; 1: 1-17.
30. Tessitore L et al. Cancer cachexia, malnutrition, and tissue protein turnover in experimental animals. Arch Biochem Biophys. 1993; 306: 52-8.
31. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987; 162: 156-9.
32. Bai L, Pang WJ, Yang GS. Sirt1: a novel adipocyte and myocyte regulatory factor. Yi Chuan. 2006; 28: 1462-6.
33. Fulco M et al. Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt. Dev Cell. 2008; 14: 661-73.
34. Costelli P et al. Tumor necrosis factor-alpha mediates changes in tissue protein turnover in a rat cancer cachexia model. J Clin Invest. 1993; 92: 2783-9.
35. Garcia-Martinez C et al. Ubiquitin gene expression in skeletal muscle is increased by tumour necrosis factor-alpha. Biochem Biophys Res Commun. 1994; 201: 682-6.
36. Carbo N et al. Anti-tumour necrosis factor-alpha treatment interferes with changes in lipid metabolism in a tumour cachexia model. Clin Sci (Lond). 1994; 87: 349-55.
37. Zhang HN et al. Involvement of the p65/RelA subunit of NF-kappaB in TNF-alpha-induced SIRT1 expression in vascular smooth muscle cells. Biochem Biophys Res Commun. 2010; 397: 569-75.
38. Machida S, Booth FW. Increased nuclear proteins in muscle satellite cells in aged animals as compared to young growing animals. Exp Gerontol. 2004; 39: 1521-5.
39. Alamdari N et al. Sepsis and glucocorticoids upregulate p300 and downregulate HDAC6 expression and activity in skeletal muscle. Am J Physiol Regul Integr Comp Physiol. 2010; 299: R509-20.
40. Zammit PS et al. Muscle satellite cells adopt divergent fates: a mechanism for self-renewal? J Cell Biol. 2004; 166: 347-57.
41. Yablonka-Reuveni Z, Rivera AJ. Temporal expression of regulatory and structural muscle proteins during myogenesis of satellite cells on isolated adult rat fibers. Dev Biol. 1994; 164: 588-603.
42. Nagata Y et al. Sphingomyelin levels in the plasma membrane correlate with the activation state of muscle satellite cells. J Histochem Cytochem. 2006; 54: 375-84.
43. Amat R et al. SIRT1 controls the transcription of the peroxisome proliferator-activated receptor-gamma Co-activator-1alpha (PGC-1alpha) gene in skeletal muscle through the PGC-1alpha autoregulatory loop and interaction with MyoD. J Biol Chem. 2009; 284: 21872-80.
44. Fuster G et al. Are peroxisome proliferator-activated receptors involved in skeletal muscle wasting during experimental cancer cachexia? Role of beta2-adrenergic agonists. Cancer Res. 2007; 67: 6512-9.
45. Argiles JM et al. Cross-talk between skeletal muscle and adipose tissue: a link with obesity? Med Res Rev. 2005; 25: 49-65.
46. von Haehling S et al. Ethical guidelines for authorship and publishing in the Journal of Cachexia Sarcopenia and Muscle. J Cachexia Sarcopenia Muscle. 2010; 1: 7-8.